Papers
1
Total Citations
27
H-Index
1
About
Dr. E. Parisi is a leading surgical oncologist whose work has fundamentally reshaped the management of oropharyngeal squamous cell carcinomas (OPSCC) through the advancement of trans-oral robotic surgery (TORS). With a career focused on minimally invasive head and neck oncology, Dr. Parisi’s landmark 2019 study, "Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience," has garnered 27 citations, serving as a critical reference for surgeons worldwide. This comprehensive analysis provided robust, long-term evidence on both surgical and oncologic outcomes for patients treated with TORS, both with and without adjuvant therapy, demonstrating the procedure’s efficacy in reducing morbidity while maintaining excellent disease control. By systematically evaluating a large institutional cohort over nearly a decade, Dr. Parisi helped establish TORS as a standard-of-care alternative to traditional open surgery, significantly improving recovery times and quality of life for patients. This work has been instrumental in guiding clinical protocols and training the next generation of head and neck surgeons, cementing Dr. Parisi’s reputation as a pivotal figure in the evolution of robotic-assisted oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1